Health & Bio
Seaport, Hemab combine $556M IPO, biotech momentum
Two companies debut together on $556M, year-to-date 10 public launches at $3.2B—biotech IPO market in recovery.
Primary sources · 2
Two companies debut together on $556M, year-to-date 10 public launches at $3.2B—biotech IPO market in recovery.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.